Yara Cury Selected Research

Yara Cury Research Topics

Disease

19	Hyperalgesia 01/2019 - 04/2003
15	Pain (Aches) 12/2022 - 03/2004
6	Inflammation (Inflammations) 12/2017 - 07/2009
5	Neoplasms (Cancer) 08/2018 - 05/2007
4	Neuralgia (Stump Neuralgia) 12/2017 - 10/2008
3	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2022 - 12/2017
3	Edema (Dropsy) 01/2017 - 04/2003
2	Osteoarthritis 12/2022 - 01/2019
2	Myotoxicity 01/2017 - 06/2010
2	Cancer Pain 08/2013 - 05/2007
1	Neuroinflammatory Diseases 12/2022
1	Diabetic Neuropathies (Diabetic Neuropathy) 12/2022
1	Melanoma (Melanoma, Malignant) 01/2019
1	Bone Neoplasms (Bone Cancer) 08/2018
1	Arthritis (Polyarthritis) 01/2017
1	Hypersensitivity (Allergy) 11/2016
1	Breast Neoplasms (Breast Cancer) 09/2015
1	Carcinoma (Carcinomatosis) 08/2013

Drug/Important Bio-Agent (IBA)

14	VenomsIBA 12/2017 - 04/2003
9	Analgesics (Analgesic Drugs)IBA 01/2019 - 09/2006
7	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2017 - 03/2004
5	Opioid Analgesics (Opioids)IBA 01/2019 - 09/2004
5	crotalphineIBA 11/2016 - 08/2008
5	ProstaglandinsIBA 08/2008 - 05/2003
3	Morphine (MS Contin)FDA LinkGeneric 01/2019 - 05/2007
3	Phospholipases (Phospholipase)IBA 12/2017 - 03/2004
3	Indomethacin (Indometacin)FDA LinkGeneric 01/2017 - 09/2004
3	CrotoxinIBA 01/2016 - 12/2008
3	Peptides (Polypeptides)IBA 02/2012 - 10/2008
3	CarrageenanIBA 08/2008 - 05/2003
3	CytokinesIBA 09/2004 - 03/2004
2	Advanced Glycation End ProductsIBA 12/2022 - 01/2019
2	Capsaicin (Zostrix)FDA Link 01/2019 - 09/2015
2	Serotonin ReceptorsIBA 12/2017 - 12/2008
2	Amino Acids FDA Link 01/2017 - 02/2012
2	Celecoxib (Celebrex)FDA Link 01/2017 - 09/2004
2	Interleukin-6 (Interleukin 6)IBA 01/2017 - 03/2004
2	delta Opioid Receptors (delta Opioid Receptor)IBA 08/2013 - 06/2004
2	Adenosine Triphosphate (ATP)IBA 02/2012 - 05/2003
2	Opioid Receptors (Opioid Receptor)IBA 02/2012 - 10/2008
2	TachykininsIBA 09/2004 - 04/2003
2	Glutamate Receptors (Glutamate Receptor)IBA 09/2004 - 04/2003
2	7-nitroindazoleIBA 09/2004 - 09/2004
2	Secretory Phospholipases A2IBA 09/2004 - 03/2004
2	Snake Venoms (Snake Venom)IBA 09/2004 - 03/2004
1	Substance PIBA 12/2022
1	TubulinIBA 12/2022
1	NeuropeptidesIBA 12/2022
1	CollagenIBA 12/2022
1	ThioureaIBA 01/2019
1	Dinoprostone (PGE2)FDA Link 01/2019
1	Carrier Proteins (Binding Protein)IBA 01/2019
1	LipidsIBA 01/2019
1	Pharmaceutical PreparationsIBA 01/2019
1	SugarsIBA 01/2019
1	ElementsIBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2019
1	Mitogen-Activated Protein KinasesIBA 01/2019
1	OligodeoxyribonucleotidesIBA 01/2019
1	Technetium Tc 99m MedronateIBA 08/2018
1	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 12/2017
1	bunodosine 391IBA 12/2017
1	Formaldehyde (Formol)FDA Link 12/2017
1	KetanserinIBA 12/2017
1	Ondansetron (Zofran)FDA LinkGeneric 12/2017
1	Phospholipids (Phosphatides)FDA LinkGeneric 12/2017
1	Bothrops asper myotoxin IIIBA 01/2017
1	zileuton (Zyflo)FDA Link 01/2017
1	icatibantIBA 01/2017
1	bothropstoxinIBA 01/2017
1	N- (2(R)- 2- (hydroxamidocarbonylmethyl)- 4- methylpentanoyl)- L- tryptophan methylamideIBA 01/2017
1	arachidonyltrifluoromethaneIBA 01/2017
1	palmitoyl trifluoromethyl ketoneIBA 01/2017
1	ilomastatIBA 01/2017
1	AntibodiesIBA 01/2017
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2017
1	Methysergide (Sansert)FDA Link 01/2017
1	Promethazine (Promet)FDA LinkGeneric 01/2017
1	Serotonin AntagonistsIBA 01/2017
1	Lipoxygenase InhibitorsIBA 01/2017
1	Cyclooxygenase InhibitorsIBA 01/2017
1	Endothelin Receptors (Endothelin Receptor)IBA 01/2017
1	Bradykinin B2 ReceptorIBA 01/2017
1	Bradykinin B1 ReceptorIBA 01/2017
1	Metalloproteases (Metalloproteinases)IBA 01/2017
1	Phospholipases A2 (Phospholipase A2)IBA 01/2017
1	Calcitonin Gene-Related PeptideIBA 11/2016
1	Ion Channels (Ion Channel)IBA 11/2016
1	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 01/2016
1	LipoxinsIBA 01/2016
1	lipoxin A4IBA 01/2016
1	SulfonamidesIBA 09/2015
1	AldehydesIBA 08/2014
1	EnzymesIBA 08/2014
1	Narcotics (Narcotic Analgesics)IBA 08/2014
1	Cyclic GMPIBA 02/2012

Therapy/Procedure

5	Therapeutics 09/2015 - 09/2006
3	Subcutaneous Injections 01/2019 - 03/2004
3	Analgesia 01/2019 - 10/2011